| Literature DB >> 21856199 |
Matthew D Hirschey1, Tadahiro Shimazu, Enxuan Jing, Carrie A Grueter, Amy M Collins, Bradley Aouizerat, Alena Stančáková, Eric Goetzman, Maggie M Lam, Bjoern Schwer, Robert D Stevens, Michael J Muehlbauer, Sanjay Kakar, Nathan M Bass, Johanna Kuusisto, Markku Laakso, Frederick W Alt, Christopher B Newgard, Robert V Farese, C Ronald Kahn, Eric Verdin.
Abstract
Acetylation is increasingly recognized as an important metabolic regulatory posttranslational protein modification, yet the metabolic consequence of mitochondrial protein hyperacetylation is unknown. We find that high-fat diet (HFD) feeding induces hepatic mitochondrial protein hyperacetylation in mice and downregulation of the major mitochondrial protein deacetylase SIRT3. Mice lacking SIRT3 (SIRT3KO) placed on a HFD show accelerated obesity, insulin resistance, hyperlipidemia, and steatohepatitis compared to wild-type (WT) mice. The lipogenic enzyme stearoyl-CoA desaturase 1 is highly induced in SIRT3KO mice, and its deletion rescues both WT and SIRT3KO mice from HFD-induced hepatic steatosis and insulin resistance. We further identify a single nucleotide polymorphism in the human SIRT3 gene that is suggestive of a genetic association with the metabolic syndrome. This polymorphism encodes a point mutation in the SIRT3 protein, which reduces its overall enzymatic efficiency. Our findings show that loss of SIRT3 and dysregulation of mitochondrial protein acetylation contribute to the metabolic syndrome.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21856199 PMCID: PMC3563434 DOI: 10.1016/j.molcel.2011.07.019
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970